Viewing Study NCT03836105

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-02-20 @ 6:35 PM
Study NCT ID: NCT03836105
Status: COMPLETED
Last Update Posted: 2025-10-15
First Post: 2019-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: CemiplimAb Survivorship Epidemiology
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cutaneous Squamous Cell Carcinoma View
None Basal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally Advanced CSCC (laCSCC) View
None Metastatic CSCC (mCSCC) View
None Locally Advanced BCC (laBCC) View
None Metastatic BCC (mBCC) View